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Summary
The Salvador-Warts-Hippo (SWH) pathway is an evolution-
arily conserved regulator of tissue growth that is deregu-
lated in human cancer [1–3]. Upstream SWH pathway
components convey signals from neighboring cells via a
core kinase cassette to the transcription coactivator Yorkie
(Yki) [4]. Yki controls tissue growth by modulating activity
of transcription factors including Scalloped (Sd) [1–3]. To
date, five SWH pathway kinases have been identified,
but large-scale phosphoproteome studies suggest that
unidentified SWH pathway kinases exist [5, 6]. To identify
such kinases, we performed an RNA interference screen
and isolated homeodomain-interacting protein kinase
(Hipk). Unlike previously identified SWH pathway kinases,
Hipk is unique in its ability to promote, rather than repress,
Yki activity and does so in parallel to the Yki-repressive
kinase, Warts (Wts). Hipk is required for basal Yki activity
and is likely to regulate Yki function by promoting its
accumulation in the nucleus. Like many SWH pathway
proteins, Hipk’s function is evolutionarily conserved as
its closest human homolog, HIPK2, promotes activity of
the Yki ortholog YAP in a kinase-dependent fashion.
Further, HIPK2 promotes YAP abundance, suggesting
that the mechanism by which HIPK2 regulates YAP has
diverged in mammals.
Results and Discussion
To identify new Salvador-Warts-Hippo (SWH) pathway
kinases, we crossed UAS-inducible RNAi lines representing
each Drosophila melanogaster kinase to a strain harboring
both the eye-specific promoter GMR-Gal4 and a UAS-ex
transgene (GMR-ex). When crossed to a control RNAi line,
GMR-ex overexpression caused a partial reduction in eye
size, providing an ideal modifiable phenotype for a genetic
screen. We identified several kinases that, when depleted
by RNAi, caused a modification in the size of eyes co-overex-
pressing ex. One such kinase was homeodomain-interacting
protein kinase (Hipk) that when knocked down caused a
further reduction in the size of GMR-ex eyes. Hipk was vali-
dated as a potential regulator of the SWH pathway because
a loss-of-function hipk allele (hipk3) also dominantly reduced
the size of GMR-ex eyes (see Figures S1A–S1C available
online).*Correspondence: kieran.harvey@petermac.orgHipk Controls Tissue Growth and Salvador-Warts-Hippo
Pathway Activity
To investigate the function of Hipk further, we modulated its
expression using UAS-inducible hipk transgenes. Previous
studies have shown that eye-specific hipk overexpression
results in overgrowth of the eye [7]. To determine whether
hipk overexpression could promote wing overgrowth, we
overexpressed two independent hipk transgenes (UAS-hipk II
and UAS-hipk III) using the 71B-Gal4 driver, resulting in
wings that were significantly increased in size compared to
control wings. (Figures 1A–1C and 1E). To determine whether
this overgrowth was due to Yorkie (Yki) hyperactivation, we
repeated this experiment in a yki hemizygous background. In
this scenario, tissue growth was suppressed, suggesting
that Yki hyperactivation contributes to Hipk-dependent tissue
overgrowth (Figures 1D and 1E).
To test this idea further, we used quantitative real-time
(RT)-PCR to measure messenger RNA (mRNA) levels of a
well-described Yki target gene, ex [8], in wing discs expressing
UAS-hipk transgenes under the control of 32B-Gal4. exmRNA
levels were almost 2-fold higher in wing imaginal discs that
overexpressed hipk compared to control discs (Figure 1F),
suggesting that Hipk promotes Yki transcriptional activity. To
confirm this result, we analyzed expression of exmRNA (using
an ex-lacZ enhancer trap), Ex protein (using an Ex-specific
antibody), and another key Yki target gene ban [9, 10], using
a GFP-based ban sensor. In tissue that overexpressed
UAS-hipk II or UAS-hipk III under the control of hh-Gal4, ex
mRNA, Ex protein, and ban activity were elevated compared
to control tissue in the anterior wing disc compartment
(Figures 1G–1I’’ and Figures S1F–S1H). Collectively, these
data support the notion that Hipk controls tissue growth by
promoting Yki activity.
To more definitively investigate Hipk’s growth regulatory
function, we used RNAi and a mutant hipk allele to study the
role of endogenous Hipk protein. When two independent
Hipk RNAi transgenes (UAS-HipkRi 1 and UAS-HipkRi 2)
were expressed separately in the posterior compartment of
the developing wing, using hedgehog (hh)-Gal4, a significant
decrease in organ size was observed, demonstrating that
Hipk is required for wing growth (Figures 2A–2D). To establish
whether Hipk is required for basal Yki activity, we used the
Flp/FRT technique to generate clones of hipk4 mutant tissue
in developing larval imaginal discs. Yki activity, as assessed
by detection of both ex-lacZ and Ex, was decreased in hipk4
clones compared to neighboring wild-type (WT) tissue,
showing that Hipk is required to promote basal activity of
Yki (Figures 2E–2F’’). Interestingly, a reduction in ex-lacZ levels
was more prominent in hipk4 mutant clones located in the
distal rather than the proximal region of the wing pouch, sug-
gesting that Hipk regulates Yki activity in a spatially-restricted
fashion. However, we did observe reduced Ex expression in
hipk4 clones in proximal wing pouch clones as well as clones
in the hinge and notum (Figures 2F–2F’’; data not shown).
The fact that ex-lacZ and Ex levels were reduced, but not
abolished, in hipk clones and that hipk clones survive and
grow better than yki clones [11] imply that Hipk is required
for optimal Yki activity but is not essential for it. This suggests
Figure 1. Hipk Promotes Tissue Growth and Salvador-Warts-Hippo
Pathway Activity
(A–D) Adult female wings (anterior is to the left) expressing the following
transgenes under the control of 71B-Gal4: (A) UAS-LacZ, (B) UAS-hipk III,
(C) UAS-hipk II, and (D) UAS-hipk II in a fly that is also hemizygous for
ykiB5.
(E) Quantification of total wing area of the genotypes displayed in (A–D).
n = 14, 21, 14, and 11, respectively. Results represent mean 6 SEM,
*** indicates p < 0.001, ** indicates p < 0.01.
(F) ex mRNA expression relative to Actin5C mRNA in wing imaginal discs
expressing the indicated transgenes under the control of 32B-Gal4. Results
represent mean 6 SEM n = 3, and * indicates p < 0.05. In wing discs ex-
pressing UAS-hipk II the change in ex mRNA levels was not significant but
was trending toward significance (p = 0.05).
(G–I’’) Third-instar larval wing imaginal discs (anterior is to the left) ex-
pressing UAS-hipk II under control of hh-Gal4 and reporting Yki activity
with ex-lacZ (G–G’’), Ex protein (H–H’’), or a ban GFP sensor (I–I’’). Scale
bars represent 100 mM. See also Figure S1.
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a minor regulatory effect on the overall pool of Yki protein in
the cell.
Hipk Controls Yorkie Activity Downstream of or in Parallel
to Warts
To investigate at which point in the SWH pathway Hipk exerts
its function, we performed genetic epistasis experiments.
Initially, we determined whether Hipk RNAi could suppress
tissue overgrowth caused by RNAi-mediated depletion of
either the upstream SWH pathway component Ex or the core
kinase cassette protein Hpo. When either Ex or Hpo were
depleted by expressing RNAi transgenes specific for these
proteins using engrailed (en)-Gal4, posterior wing size was
substantially enlarged. When Hipk was codepleted with
either Ex or Hpo, tissue overgrowth was significantly reduced
(Figures 3A–3D and 3G), suggesting that Hipk functions
downstream of, or in parallel to, the core SWH pathway kinase
cassette.
To investigate this further, we assessed the relationship
between Hipk andWarts (Wts), the most downstreammember
of the core kinase cassette whose key role is to inhibit Yki
localization and activity. Expression of wts RNAi using en-
Gal4 causes overgrowth of the posterior domain of the wing
(Figure 3E). The wts RNAi overgrowth phenotype was sig-
nificantly suppressed upon codepletion of hipk using RNAi
(Figures 3F and 3G). This suggested that Hipk could be
acting downstream of or in parallel to Wts. Next, we examined
the effect of loss of Hipk in wts null mutant tissue using the
eyFLP/MARCM system to generate clones in eye tissue.
When wtsmutant tissue is induced in developing eye imaginal
discs, substantial overgrowth of the eye antennal disc occurs
along with lethality at the late larval and early pupal stages of
development [12]. When Hipk was depleted by RNAi in wts
mutant eye tissue, animals were able to progress further
in development and early pupal lethality was partially sup-
pressed, suggestive of reduced Yki activity (Figure 3H).
Consistent with this idea, we found that Hipk depletion sup-
pressed overgrowth of the D. melanogaster eye caused by
overexpression of Yki-S168A, a hyperactive Yki protein that
is largely impervious to Wts-mediated repression (Figures
S1D and S1E). Altogether, these data favor a scenario whereby
Hipk regulates Yki activity either downstream of or in parallel
to Wts, rather than upstream of the core kinase cassette.
Hipk Regulates the Subcellular Localization of Yorkie
We then investigated the mechanism by which Hipk regulates
Yki-dependent tissue growth. Given that simply overexpress-
ing yki can drive tissue overgrowth [11], we used immunoblot-
ting to measure Yki protein levels relative to tubulin (which
served as a loading control) in wing discs overexpressing
two independent hipk transgenes with 32B-Gal4. A 1.8-fold
increase in Yki protein was observed when hipk (III) was over-
expressed, but very little increase was observed when hipk
(II) was overexpressed (1.1-fold, values represent the mean
of two western blots; Figure 3I). The fact that both transgenes
activated Yki and promoted tissue growth (Figure 1; Figures
S1F–S1H), but did not both cause elevation of Yki levels,
suggests that Hipk does not promote Yki activity by regu-
lating its expression.
The SWH pathway represses Yki activity by promoting its
accumulation in the cytoplasm [13–15]. To investigate whether
Hipk regulates Yki localization, we overexpressed Yki either
alone or together with Hipk in third-instar larval wing imaginal
Figure 2. Hipk Is Required for Optimal Yorkie Activity
(A–C) Adult female D. melanogaster wings (anterior is to the left) expressing the following transgenes under the control of hh-Gal4: (A) UAS-LacZ RNAi; (B)
UAS-Hipk RNAi 1, and (C) UAS-Hipk RNAi 2.
(D) Quantification of the wing area posterior to the L3 vein (false colored in green) of the genotypes displayed in (A–C). Results represent mean6 SEM n = 21
for each genotype, and *** indicates p < 0.001.
(E–F’’) Third-instar larval wing imaginal discs harboring hipk4 loss-of-function clones, which fail to express GFP (green). Yki activity was examined by
assessing ex-lacZ (E–E’’) or Ex protein (F–F’’), both shown in grayscale. Yellow arrows indicate hipk4 tissue with reduced Yki activity, whereas white arrow-
heads denote hipk4 tissue with normal Yki activity. Scale bars represent 50 mM.
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1589discs using en-Gal4. Although coexpression of both Yki and
Hipk delayed larval development and resulted in lethality,
a small percentage of larvae reached third-instar larval stage
and the wing discs of these animals were analyzed for Yki
localization by immunohistochemistry. In control tissue, Yki
was predominantly cytoplasmic (Figures 3J–3K). By contrast,
in tissue that overexpressed both Hipk and Yki, Yki was
evident in both the nucleus and cytoplasm (Figures 3L–3M),particularly within the dorsal region of the wing pouch. These
observations were confirmed by taking a X–Z section in the
dorsal region of the wing pouch and quantifying the amount
of nuclear Yki (expressed as a ratio of Yki:DAPI relative
intensity) under both experimental conditions. In this region,
the Yki:DAPI ratio when Yki was expressed alone was 0.47
compared with 0.94 when Hipk was co-overexpressed with
Yki (Figures 3K’’’ and 3M’’’, respectively). These data suggest
Figure 3. Hipk Controls Yorkie Activity in Parallel to Warts
(A–F) Adult female D. melanogaster wings were too overgrown to mount flat onto glass slides; therefore, adult male D. melanogaster wings were mounted
and measured. Adult male D. melanogaster wings (anterior is to the left) expressing the following transgenes under the control of en-Gal4: (A) UAS-ex
RNAi and UAS-LacZ RNAi, (B) UAS-ex RNAi and UAS-Hipk RNAi 2, (C) UAS-hpo RNAi and UAS-LacZ RNAi, (D) UAS-hpo RNAi and UAS-Hipk RNAi 2,
and (E) UAS-wts RNAi and UAS-LacZ RNAi, and (F) UAS-wts RNAi and UAS-Hipk RNAi 2.
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1591that inD.melanogasterwing imaginal discs, Hipk regulates Yki
activity by promoting its nuclear localization.Hipk’s Ability to Regulate the SWH Pathway Is
Evolutionarily Conserved and Dependent on Its Kinase
Domain
Key components of the SWH pathway are conserved in
mammals. To determine whether Hipk’s SWH pathway regula-
tory activity is conserved in mammals, we co-overexpressed
the closest human Hipk homolog HIPK2 or a kinase-dead
version of HIPK2, HIPK2-K221A (HIPK2-KD), in 293T cells
together with YAP2L and assessed YAP activity using a TEA
domain (TEAD) transcription factor dependent luciferase
assay. In the presence of HIPK2, YAP activity was elevated
1.6-fold (Figure 4A) showing that Hipk’s ability to promote
Yki activity is conserved in mammalian cells. By contrast,
expression of HIPK2-KD did not alter YAP2L activity, showing
that HIPK2’s kinase activity is required for its ability to regulate
YAP2L (Figure 4A). We also assessed whether HIPK2 influ-
enced YAP2L expression levels. In the presence of HIPK2
overexpression, YAP2L levels were approximately 4.6-fold
higher thanwhen YAP2Lwas overexpressed alone. Consistent
with the results from luciferase assays in Figure 4A, overex-
pression of HIPK2-KD did not alter YAP2L protein levels
(Figure 4B) showing that HIPK2 requires its kinase activity to
regulate YAP2L. HIPK2’s capacity to promote YAP abundance
is a plausible explanation for its ability to increase YAP activity
as the TEAD-dependent luciferase assay employed here is
sensitive to the dose of both YAP and HIPK2 (Figures S2A
and S2B).
We also examined whether HIPK2 regulates YAP activity in
parallel to upstream SWH pathway components, akin to
Hipk-dependent regulation of Yki in D. melanogaster. The
mammalian Wts orthologs, LATS1 and LATS2, phosphorylate
YAP on several serine residues, most notably S127 [13]. To
determine whether HIPK2 promotes YAP activity by interfering
with LATS1- and LATS2-mediated phosphorylation of YAP,
we assessed YAP-S127 phosphorylation in the presence and
absence of HIPK2. Levels of YAP-S127 phosphorylation
closely matched total YAP protein expression in the presence
of HIPK2 overexpression, suggesting that HIPK2 does not
activate YAP by repressing LATS1 and LATS2-mediated phos-
phorylation (Figure 4B).
To investigate this idea further, we overexpressed HIPK2
or HIPK2-KD with YAP2, YAP2L-S127A (which lacks the major
LATS1 and LATS2 regulatory site) or YAP2-5SA (a version of
YAP lacking all known LATS1 and LATS2 phosphorylation
sites that is impervious to LATS1- and LATS2-mediated
repression [13]) in 293T cells, and YAP activity and levels
were assessed. This experimental approach also provided
us with a means to test a potential relationship between
HIPK2, the ubiquitin-ligase, Skp1-Cul1-F-box (SCF)b-TRCP,(G) Quantification of the wing area posterior to the L3 wing vein of the genotyp
represent mean 6 SEM, and *** indicates p < 0.001.
(H) Loss of Hipk inwtsXImutant eyFLP/MARCM clones promotes further pupal d
animals (total n = 85). Pupal lethality was scored as follows: early white pupae w
discernible adult eye and/or wing structures through the pupal case were class
wings, legs, and abdominal bristles through the pupal case were classed as p
(I) Immunoblots were probed with the indicated antibodies on protein lysates
hipk II, or UAS-hipk III were expressed with 32B-Gal4.
(J–J’’’) Third-instar larval wing imaginal disc (anterior is to the left) expressingU
en-Gal4. Yki expression (J, K, L, M), DAPI (J’, K’, L’, M’), and Hipk (J’’, K’’, L
(K’’’ and M’’’). Scale bar is 50 mM.and YAP. HIPK2 has been shown to repress SCFb-TRCP activity
[16], whereas SCFb-TRCP targets YAP for ubiquitin-mediated
proteolysis in response to phosphorylation of YAP S381 by
LATS1 and LATS2 and YAP S384 by Casein Kinase 1d/ε [17].
Therefore, we reasoned that if HIPK2 increases YAP abun-
dance by repressing SCFb-TRCP, it should have no influence
on YAP2-5SA activity or abundance. TEAD-dependent lucif-
erase assays showed that HIPK2, but not HIPK2-KD, activated
both YAP2 and YAP2-5SA to similar degrees (Figure 4C). In
addition, HIPK2, but not HIPK2-KD, caused (1) an increase in
YAP2L-S127A, YAP2, and YAP2-5SA levels, as determined
by immunoblotting, and (2) did not impede phosphorylation
of YAP-S127 (Figures 4B and 4D). These data imply that
HIPK2 kinase activity regulates YAP abundance independent
of its ability to regulate SCFb-TRCP and in parallel to LATS1
and LATS2.
We also determined whether reducing endogenous HIPK2
expression influenced YAP2L’s abundance and its ability to
activate TEAD2. 293T cells were transfected with YAP2L
plasmid and either control nontargeting small interfering
RNA (siRNA) oligos or Hipk2 siRNA oligos. When HIPK2 was
knocked down, YAP’s ability to activate TEAD2 was signifi-
cantly reduced, compared to control siRNA (Figure 4E). We
failed to detect endogenous HIPK2 protein expression in
293T cells using available antibodies and therefore used
quantitative RT-PCR to confirm thatHipk2mRNAwas reduced
in the presence ofHipk2 siRNA (Figure 4F). Consistent with our
finding that reduction of HIPK2 expression can influence YAP
activity, we found that YAP2L protein levels in YAP-transfected
cells were substantially lower in cells where endogenous
HIPK2 expression was reduced (Figure 4G). Together with
our in vivo genetic data, these results show that in both
Drosophila and mammalian cells, Hipk/HIPK2 regulate Yki/
YAP activity by acting in parallel to Wts/LATS1 and LATS2.
In addition, in mammalian cells, HIPK2 possibly influences
YAP activity by promoting YAP abundance, whereas in
D. melanogaster tissues, Hipk affects Yki localization.Conclusions
The data presented here describe Hipk as the first identified
kinase that positively regulates Yki-dependent tissue growth.
Hipk activates Yki by acting in parallel to upstream SWH
pathway proteins that impinge on Wts to induce phosphoryla-
tion of Yki. Further, Hipk regulates subcellular localization of
Yki in developing wing tissue, promoting nuclear localization
of Yki. Hipk’s ability to regulate the SWH pathway is
conserved in mammals because HIPK2 regulates YAP in
parallel to LATS1 and LATS2. In addition, HIPK2 requires its
kinase domain to regulate YAP; however, YAP does not
appear to be a direct target of HIPK2 because we did not
detect any evidence that HIPK2 stimulates phosphorylation
of YAP or that Hipk stimulates phosphorylation of Yki (Figureses displayed in (A)–(F). n = 11, 20, 11, 22, 12, and 37, respectively. Results
evelopment (total n = 168) compared towtsXImutant eyFLP/MARCM control
ere classed as early pupal stage (pale gray bars) pupae that contained either
ed as midpupal stage (mid gray bars) and pupae with discernible adult eyes,
harate adults (dark gray bars). No adult escapers were observed.
from third-instar larval wing imaginal discs where UAS-lacZ control, UAS-
AS- yki.V5 (J–K’’’) orUAS-yki.V5 andUAS-Hipk II (L–M’’’) under the control of
’’, M’’) is greyscale, except for merges where Yki is green and DAPI is red
Figure 4. HIPK’s Ability to Regulate the SWH Pathway Is Evolutionarily Conserved and Dependent on Its Kinase Domain
(A) Luciferase assay measuring the capability of YAP2L to activate TEAD2 in 293T cells expressing the indicated plasmids.
(B) Immunoblots performed with the indicated antibodies on lysates from 293T cells transfected with the following plasmids: empty vector control (C),
YAP2L (Y), YAP2L-S127A (S), HIPK2 (H), or HIPK2-KD (KD).
(C) Luciferase assay measuring the capability of YAP2 (Y) or hyperactivated YAP2 (5SA) to activate TEAD2 in 293T cells expressing the indicated
plasmids.
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1593S2C and S2D). We also failed to detect physical interactions
between HIPK2 and YAP, or Hipk2 and Yki, even when
kinase-dead versions of HIPK2 or Hipk were used (data not
shown). These data point to the existence of unknown
intermediate proteins phosphorylated by HIPK2/Hipk that
influence YAP/Yki abundance or activity. Hipk is known to
regulate Wg, N, and Hh signaling [7, 16] and therefore might
serve as a point of convergence between morphogen
signaling and the SWH pathway, which is thought to regulate
organ size by conveying information about cell density and
mechanical tension [18]. Given that the SWH pathway is
deregulated in human cancer, our findings raise the possibility
that aberrant HIPK2 activity contributes to carcinogenesis in
humans. HIPK2 has previously been implicated in human
cancer but its precise role is controversial, with evidence
supporting both tumorigenic and oncogenic activity of
HIPK2 [19, 20]. Our findings that Hipk promotes Yki-depen-
dent growth of D. melanogaster tissues and that HIPK2 acti-
vates YAP in human cells are consistent with an oncogenic
role for HIPK2.Experimental Procedures
D. melanogaster Stocks
Drosophila experiments were performed at 25C. The hipk4 allele [7] was
recombined onto FRT80B and clones generated by crossing to y w hsFlp;
FRT80 P [w+ ubi2GFP]. Hipk knockdownwas performed using two different
RNAi lines: UAS-Hipk RNAi 1 (GD 32854) andUAS-Hipk RNAi 2 (KK 108254),
both from the Vienna Drosophila RNAi Center (VDRC) [21]. Other RNAi lines
used were UAS-ex RNAi (KK 109281), UAS-lacZ RNAi (GD 51446), UAS-wts
RNAi (R203739) (all VDRC), and UAS-hpo RNAi [22]. Overexpression lines
were as follows: UAS-hipk II, UAS-hipk III [7], and UAS-yki.V5 [15]. eyFlp/
MARCM clones were generated with the following stocks: w; FRT82B
wtsX1 [23], UAS-Hipk RNAi 2; FRT82B, and eyFlp, UAS-GFP; tub-GAL4
FRT82B tub-GAL80 [24]. Other stocks used were GMR-Gal4, hh-Gal4,
71B-Gal4, en-Gal4, 32B-Gal4, UAS-lacZ, and ykiB5 [11].
Immunofluorescence
Primary antibodies used were mouse anti-b-galactosidase (Sigma), rabbit
anti-Yki [15], rabbit anti-Ex [25], and rat anti-HA (Roche). Secondary anti-
bodies were from Invitrogen. Tissues were stained as in [26, 27].
Quantification of Wing Size
Either total or the area posterior of the L3 wing vein of female or male adult
wings, as indicated, was quantified using Adobe Photoshop. The mean and
SEM values of wing area were determined with GraphPad Prism. Each
genotype was compared using unpaired Student’s t tests to assess statis-
tical significance. P values < 0.05 were considered significant.
Analysis of Yki Localization
High resolution cross-sections (X–Z) were taken through wing discs using
an Olympus FV1000 confocal microscope, and average intensities were
measured using ImageJ (National Institutes of Health, NIH). To quantify
nuclear Yki protein in each cross section, we thresholded the DAPI channel
(visualizing nuclei) and used it to create a binary mask. The DAPI binary
mask was transferred to both the Yki and DAPI channels for each X–Z
section using the Image calculator Min function. The average gray value,
representing average intensity, of each channel was measured and ex-
pressed as a Yki:DAPI ratio for each X–Z section.(D) Immunoblots were probed with the indicated antibodies on lysates from 2
YAP2 (Y), YAP2L-5SA (S), or HIPK2 (H).
(E) Luciferase activity measuring the ability of YAP2L to activate TEAD2 in 293T
or HIPK2 siRNA (siHIPK2).
(F) Hipk2 mRNA expression relative to actin mRNA in 293T cells treated as in (
(G) Immunoblots of lysates from 293T cells used in (E) with antibodies specific
n = 3, **** indicates p < 0.0001, ** indicates p < 0.01, and * indicates p < 0.05.Quantitative Real-Time PCR
RNA extracted from wing imaginal discs using Trizol (Invitrogen) was used
to generate complementary DNA (cDNA) with Superscript III (Invitrogen).
Quantitative RT-PCR reactions were analyzed on Applied Biosystems
Step One Plus software with Fast SYBR Green Master Mix (Applied Bio-
systems). Primers detected ex orActin 5CmRNA inD.melanogaster tissues
as in [28, 29] or Hipk2 and actin in 293T cells.
Cell Culture
Plasmids expressed YAP2L and YAP2L-S127A [30], YAP2 and YAP2-5SA
[13], and HIPK2 and HIPK2-KD [31]. YAP/TEAD2 luciferase assays were
performed in 293T cells as described [30].
Immunoblotting
Protein lysates were collected from either third-instar larval wing discs or
293T cells 48 hr posttransfection, and subjected to SDS-PAGE and
transferred to polyvinylidene fluoride membrane (Millipore). Membranes
were immunoblotted with the following antibodies: rabbit anti-Yki [15],
rabbit anti-YAP, rabbit anti-phospho-S127-YAP, rabbit anti-actin (all Cell
Signaling), mouse anti-Tubulin, mouse anti-Flag (both Sigma), rat anti-HA
(Roche), and mouse anti-Myc (Santa Cruz Biotechnology). Protein bands
on western blots were quantified using ImageJ (NIH). The relative intensity
of Yki protein was quantified and normalized to tubulin, and the mean was
calculated from two western blots.Supplemental Information
Supplemental Information includes two figures and Supplemental Experi-
mental Procedures, and can be found with this article online at http://dx.
doi.org/10.1016/j.cub.2012.06.075.
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